Back
Range Cancer Therapeutics ETF Vs. Invesco Nasdaq Biotechnology ETF Industry Stock Comparison
Sell
44
CNCR
Range Cancer Therapeutics ETF
Last Price:
15.24
Seasonality Move:
1.85%
Sell
35
IBBQ
Invesco Nasdaq Biotechnology ETF
Last Price:
23.63
Seasonality Move:
0.4%
Sell
44
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $14.80. The Score for CNCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Invesco Nasdaq Biotechnology ETF (IBBQ)
is a Sell
Is Invesco Nasdaq Biotechnology ETF a Buy, Sell or Hold?
- The current Invesco Nasdaq Biotechnology ETF [IBBQ] share price is $23.53. The Score for IBBQ is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- IBBQ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $14.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.
IBBQ Stock Price Chart
What is Invesco Nasdaq Biotechnology ETF's stock price today?
-
The Invesco Nasdaq Biotechnology ETF share price today is $23.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IBBQ is experiencing selling pressure, which indicates risk of future bearish movement.
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 45.09 | Sell |
| Chaikin Money Flow: | -2025 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.73 - 15.45) | Sell |
| Bollinger Bands (100): | (14.08 - 15.46) | Buy |
IBBQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 44.65 | Sell |
| Chaikin Money Flow: | -37529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.48 - 24.12) | Sell |
| Bollinger Bands (100): | (23.26 - 24.32) | Sell |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.36 | Sell |
| 20-day SMA: | 15.14 | Sell |
| 50-day SMA: | 15.08 | Sell |
| 200-day SMA: | 15.09 | Sell |
| 8-day EMA: | 15.24 | Sell |
| 20-day EMA: | 15.16 | Sell |
| 50-day EMA: | 15.03 | Sell |
| 200-day EMA: | 14.63 | Buy |
IBBQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.97 | Sell |
| 20-day SMA: | 23.79 | Sell |
| 50-day SMA: | 23.84 | Sell |
| 200-day SMA: | 22.86 | Buy |
| 8-day EMA: | 23.89 | Sell |
| 20-day EMA: | 23.83 | Sell |
| 50-day EMA: | 23.79 | Sell |
| 200-day EMA: | 22.95 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Invesco Nasdaq Biotechnology ETF Earnings Growth & IBBQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Invesco Nasdaq Biotechnology ETF Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||